Medicine and Dentistry
Bladder
33%
Bladder Cancer
66%
Conservative Treatment
33%
Disease
33%
Disease Exacerbation
66%
Disease Free Survival
33%
Disease Specific Survival
33%
Immunotherapy
100%
Malignant Neoplasm
33%
Progression Free Survival
33%
Recurrence Free Survival
33%
Recurrent Disease
100%
Survival Rate
66%
Transitional Cell Carcinoma
100%
Transurethral Resection
66%
Tumor Progression
33%
Tumor Recurrence
33%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
66%
Disease
33%
Disease Exacerbation
66%
Disease Free Survival
33%
Disease Specific Survival
33%
Immunotherapy
100%
Malignant Neoplasm
33%
Progression Free Survival
33%
Recurrence Free Survival
33%
Recurrent Disease
100%
Survival Rate
66%
Transitional Cell Carcinoma
100%
Tumor Growth
33%
Tumor Recurrence
33%
Keyphrases
Bladder Transitional Cell Carcinoma
25%
Cancer Mortality
25%
Cancer Risk
25%
Consecutive Patients
25%
Conservative Treatment
25%
Disease Progression
50%
Disease-free Survival
25%
Disease-specific Survival
25%
First Year
25%
High Risk
25%
High-grade Bladder Cancer
50%
Intravesical
50%
Progression-free Survival
25%
Recurrence-free Survival
25%
Stage Ta
25%
T1 High Grade
100%
Transitional Cell Carcinoma
100%
Transurethral Resection
50%
Tumor Progression
25%
Tumor Recurrence
25%
Immunology and Microbiology
Carcinoma Cell
100%
Disease Free Survival
33%
Disease Specific Survival
33%
Immunotherapy
100%
Progression Free Survival
33%
Recurrence Free Survival
33%
Survival Rate
66%